Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx

Final results of nilotinib versus nilotinib combined with pegylated interferon alfa-2a as first-line therapy in chronic phase chronic myeloid leukaemia in France (PETALs): an open-label, multicentre, randomised phase 3 trial - The Lancet Haematology thelancet.com/journals/lanha…

Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host Disease | Journal of Clinical Oncology ascopubs.org/doi/pdf/10.120…

From Molecular Complexity to Personalized Care in Chronic Myelomonocytic Leukemia | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

Circulating Tumor DNA Assessment of Disease Response in Large B-Cell Lymphoma: Lisocabtagene Maraleucel Versus Autologous Stem Cell Transplantation Standard Therapy | Journal of Clinical Oncology ascopubs.org/doi/pdf/10.120…

Trends in survival outcomes after allogeneic transplantation for MDS and MDS/MPN in a real-world experience: A 25-year nationwide study onlinelibrary.wiley.com/doi/10.1111/bj…

Treosulfan–fludarabine conditioning in infants with severe combined immunodeficiencies: Extended study of the UK paediatric treosulfan study onlinelibrary.wiley.com/share/RPCKT8HA…

Asciminib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Case Series and Review of Emerging Evidence | MDPI share.google/LO0wVH5Og8aif0…

Concomitant or sequential lower intensity triplet therapy in AML - The Lancet Haematology thelancet.com/journals/lanha…

Oral deucrictibant for prophylaxis of hereditary angioedema attacks (CHAPTER-1): primary analysis of a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Haematology thelancet.com/journals/lanha…

Who will watch the watchmen: unique challenges of T-cell redirecting therapies in T-cell malignancies - The Lancet Haematology thelancet.com/journals/lanha…

Randomized trial of GvHD Prophylaxis in Haploidentical PBSC Transplantation: ATG, PTCy, and Low-Dose Combination Therapy ashpublications.org/blood/article-…

Ferric Carboxymaltose Increases Fracture Risk in Patients and Reduces Bone Formation in Mice with Iron Deficiency Anemia ashpublications.org/blood/article/…

Discovery and preclinical activity of the menin-KMT2A inhibitor ziftomenib in acute leukemia models ashpublications.org/blood/article-…

Tocilizumab as stabilizing frontline treatment in suspected KSHV inflammatory cytokine syndrome ashpublications.org/bloodadvances/…

Early Steroid and Anakinra Use to Manage Axicabtagene Ciloleucel Toxicity Reduces the Total Duration of CRS and ICANS ashpublications.org/bloodadvances/…

Pulmonary Complications Following Hematopoietic Cell Transplantation in Patients with Myelofibrosis: astctjournal.org/article/S2666-…

Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid Syndrome | New England Journal of Medicine nejm.org/doi/full/10.10…

Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain (CART19-BE-02): a multicentre, single-arm, phase 2 trial - The Lancet Haematology thelancet.com/journals/lanha…

Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia | New England Journal of Medicine nejm.org/doi/full/10.10…

DB-OTO Gene Therapy for Inherited Deafness | New England Journal of Medicine nejm.org/doi/full/10.10…